Evidence map›Paper›PMID 24693373›Full record

ArticleIranian Red Crescent medical journal2013

Serotype distribution and antibiotics susceptibility pattern of Streptococcus pneumonia in Iran.

Samira Habibian, Ali Mehrabi-Tavana, Zyanab Ahmadi, Morteza Izadi, Nematolah Jonaidi, Jalalodin Darakhshanpoure, Mahmode Salesi, Seyed Mohsen Zahraei, Ramezan Ali Ataee

Open access · bronzeAbstract read
In one paragraph

Article in Iranian Red Crescent medical journal, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Is Penicillin-NonsusceptibleScientifica · 2021
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Samira HabibianDepartment of Medical Microbiology, Tonokabon Azad University of Medical Sciences, Tonokabon, IR Iran.
Ali Mehrabi-TavanaHealth Management Research Center, Department of Medical Microbiology, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, IR Iran.
Zyanab AhmadiMolecular Biology Research Center, Baqiyatallah University of Medical Sciences, Tehran, IR Iran.
Morteza IzadiHealth Research Center, Baqiyatallah University of Medical Sciences, Tehran, IR Iran.
Nematolah JonaidiHealth Research Center, Baqiyatallah University of Medical Sciences, Tehran, IR Iran.
Jalalodin DarakhshanpoureDepartment of Medical Microbiology, Tonokabon Azad University of Medical Sciences, Tonokabon, IR Iran.
Mahmode SalesiHealth Research Center, Baqiyatallah University of Medical Sciences, Tehran, IR Iran.
Seyed Mohsen ZahraeiMinistry of Health and Medical Education, Center for Communicable Disease Control, Tehran, IR Iran.
Ramezan Ali AtaeeDepartment of Medical Microbiology, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, IR Iran.
Baqiyatallah University of Medical Sciences · IRIslamic Azad University Tonekabon · IRMinistry of Health and Medical Education · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe development of antibiotic resistance among Streptococcus pneumoniae strains has caused significant health problems worldwide.

objectivesThe aim of this study was to determine antibiotic resistance pattern and serotypes distribution of Streptococcus pneumoniae strains isolated from clinical specimens. MATERIAL AND

methodsA total of fifty Streptococcus pneumoniae strains were isolated from Tehran Hospital's laboratory from 2008 to 2012. Antimicrobial susceptibility testing was performed using broth microdilution method and minimum inhibitory concentration (MIC) of each strain was determined. to verify the resistant strains and demonstrate the presence of antibiotic resistant genes, the PCR was performed.

resultsThe study showed that three strains (6%) and six strains (12%) indicated intermediate resistance and complete resistance to penicillin, respectively, 58% strains were susceptible to ceftazidime, two ones (4%) indicated resistance to ciprofloxacin, one (2%) indicated intermediate resistance to ceftriaxone , two strains (4%) indicated complete resistance and four (8%) strains indicated resistance to vancomycin.

conclusionsThe emergence of Streptococcus pneumoniae strains with multiple resistance needs permanent monitoring of antibiotic susceptibility patterns of clinical isolates. We have found that ceftazidime is not a suitable drug for choosing the treatment of pneumococcal infections.

Indexed as

Antimicrobial susceptibilityIranStreptococcus pneumonia

Identifiers

PMID24693373
PMCPMC3950785
OpenAlexW2150851798

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.